Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Dec 06, 2022 2:44pm
93 Views
Post# 35154150

RE:$0,10

RE:$0,10s1, as expected HEXO filed for an appeal regarding the judges favourable summary judgement decision to Medipharm regarding the $9.8 million dollar plus interest award.

Sit back and relax, as the court system is anything but fast moving........................

Medipharm disclosure - "On July 25, 2022, a court ruling was issued in respect of these legal proceedings in which the Company was awarded a favourable summary judgement ruling in the amount of $9,800, plus interest and cost. In addition, the court ruling also dismissed the counterclaim of $35,000 filed against the Group. On August 23, 2022, the defendant in the Claim filed a Notice of Appeal to the summary judgment ruling. "


HEXO disclosure - "On July 25, 2022, the Company received a judgment from the Ontario Superior Court of Justice awarding the claim in favour of MediPharm Labs Inc. for the sum of $9.8 million plus interest. The Company appealed the Ontario Superior Court of Justice’s decision on August 23, 2022."


If you like reading court docs including the Reasons for the Summary Judgement Motion, enjoy!

https://www.canlii.org/en/on/onsc/doc/2021/2021onsc4823/2021onsc4823.html?autocompleteStr=medipharm&autocompletePos=1

https://www.canlii.org/en/on/onsc/doc/2022/2022onsc4326/2022onsc4326.html?autocompleteStr=medipharm%20&autocompletePos=2

<< Previous
Bullboard Posts
Next >>